20-12-2022 14:30 via wallstreet-online.de

FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate

Fast Track improves the speed and frequency of communication with FDA, potentially leading to earlier drug approval and access by patients.TORONTO, ON / ACCESSWIRE / December 20, 2022 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage …
Weiterlesen »